Fig. 10.
Fig. 10. Chimerism enhancement is not strain specific. / Chimerism levels were assessed following the same low-dose TBI/BMT transplantation regimen in chimeras created by IUHSCT in 2 different fully MHC-mismatched strain combinations. B6:Balb/c chimeras and SJL/J:B6 chimeras, formed by IUHSCT, received transplants with 30 × 106 TCD B6Pep3b and SJL/J BM cells, respectively, at 8 weeks of life 6 to 8 hours after receiving either 82.5 cGy or 276 cGy TBI. P < .05 for all chimerism values when comparing the 2 strain combinations with the exception of those indicated by an asterisk.

Chimerism enhancement is not strain specific.

Chimerism levels were assessed following the same low-dose TBI/BMT transplantation regimen in chimeras created by IUHSCT in 2 different fully MHC-mismatched strain combinations. B6:Balb/c chimeras and SJL/J:B6 chimeras, formed by IUHSCT, received transplants with 30 × 106 TCD B6Pep3b and SJL/J BM cells, respectively, at 8 weeks of life 6 to 8 hours after receiving either 82.5 cGy or 276 cGy TBI. P < .05 for all chimerism values when comparing the 2 strain combinations with the exception of those indicated by an asterisk.

Close Modal

or Create an Account

Close Modal
Close Modal